MedPath

Ketamine Hydrochloride

These highlights do not include all the information needed to use KETAMINE HYDROCHLORIDE INJECTION, safely and effectively. See full prescribing information for KETAMINE HYDROCHLORIDE INJECTION. KETAMINE HYDROCHLORIDE injection, for intravenous or intramuscular use, CIII Initial U.S. Approval: 1970

Approved
Approval ID

b96a0a23-3ca0-4a92-bd8b-1e9921931772

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Feb 23, 2023

Manufacturers
FDA

Gland Pharma Limited

DUNS: 918601238

Products 3

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Ketamine Hydrochloride

PRODUCT DETAILS

NDC Product Code68083-506
Application NumberANDA216809
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 23, 2023
Generic NameKetamine Hydrochloride

INGREDIENTS (2)

BENZETHONIUM CHLORIDEInactive
Code: PH41D05744
Classification: IACT
KETAMINE HYDROCHLORIDEActive
Quantity: 100 mg in 1 mL
Code: O18YUO0I83
Classification: ACTIM

Ketamine Hydrochloride

PRODUCT DETAILS

NDC Product Code68083-504
Application NumberANDA216809
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 23, 2023
Generic NameKetamine Hydrochloride

INGREDIENTS (3)

KETAMINE HYDROCHLORIDEActive
Quantity: 10 mg in 1 mL
Code: O18YUO0I83
Classification: ACTIM
BENZETHONIUM CHLORIDEInactive
Code: PH41D05744
Classification: IACT
SODIUM CHLORIDEInactive
Code: 451W47IQ8X
Classification: IACT

Ketamine Hydrochloride

PRODUCT DETAILS

NDC Product Code68083-505
Application NumberANDA216809
Marketing CategoryC73584
Route of AdministrationINTRAVENOUS, INTRAMUSCULAR
Effective DateFebruary 23, 2023
Generic NameKetamine Hydrochloride

INGREDIENTS (2)

KETAMINE HYDROCHLORIDEActive
Quantity: 50 mg in 1 mL
Code: O18YUO0I83
Classification: ACTIM
BENZETHONIUM CHLORIDEInactive
Code: PH41D05744
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.